Prolactinoma is one type of tumor that develops in the pituitary gland. The cause of these tumors remains unknown.
The pituitary gland is a small bean-shaped gland situated at the base of your brain. Despite its small size, the pituitary gland influences nearly every part of your body. Its hormones, such as prolactin, help regulate important functions such as growth, blood pressure and reproduction.
Other possible causes of prolactin overproduction include medications, other types of pituitary tumors, an underactive thyroid gland, an injury to the chest, pregnancy and breast-feeding.
Nov. 30, 2012
- Prolactinoma. National Institute of Diabetes and Digestive and Kidney Diseases. http://endocrine.niddk.nih.gov/pubs/prolact/prolact.htm. Accessed Jan. 17, 2011.
- Melmed S, et al. Diagnosis and treatment of hyperprolactinemia: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism. 2011;96:273.
- Colao A, et al. Therapy of aggressive pituitary tumors. Expert Opinion Pharmacotherapy. 2011;12:1561.
- Mann WA. Treatment for prolactinomas and hyperprolactinaemia: A lifetime approach. European Journal of Clinical Investigation. 2011;41:334.
- Klibanski A. Prolactinomas. The New England Journal of Medicine. 2010;352:121.
- Colao A, et al. Medical treatment of prolactinomas. Nature Reviews Endocrinology. 2011;7:267.
- Parlodel (prescribing information). East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2012. http://www.pharma.us.novartis.com/product/pi/pdf/parlodel.pdf. Accessed Nov. 13, 2012.
- Cycloset (prescribing information). San Diego, Calif.: VeroScience, LLC; 2010. http://www.veroscience.com/CyclosetFDAapprovedPackageInsert.htm. Accessed Nov. 13, 2012.
- Cabergoline (prescribing information). Sellersville, Pa.: Teva Pharmaceuticals; 2012. http://www.tevagenerics.com/default.aspx?pageid=3364&sortby=ProductName&ProductName=Cabergoline+Tablets&BrandName=Dostinex%C2%AE+Tablets. Accessed Nov. 13, 2012.
- Martinkova J, et al. Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas. Clinical Neuropharmacology. 2011;34:179.